---
title: "PRQR: AX-0811 entered the clinic, with five trial readouts and major AI-driven advances expected this year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298484540.md"
description: "Clinical dosing began for AX-0811, with five trial readouts expected across four programs in the next year. AI-driven advances have improved editing efficiency and accelerated pipeline expansion, with new data and regulatory milestones anticipated for cholestatic, MPS I, and lean MASH programs.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-09-09T16:38:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298484540.md)
  - [en](https://longbridge.com/en/news/298484540.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298484540.md)
generator: "portal-rs"
---

# PRQR: AX-0811 entered the clinic, with five trial readouts and major AI-driven advances expected this year

Clinical dosing began for AX-0811, with five trial readouts expected across four programs in the next year. AI-driven advances have improved editing efficiency and accelerated pipeline expansion, with new data and regulatory milestones anticipated for cholestatic, MPS I, and lean MASH programs.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [PRQR.US](https://longbridge.com/en/quote/PRQR.US.md)

## Related News & Research

- [ProQR Therapeutics held annual shareholder meeting in Amsterdam](https://longbridge.com/en/news/297613300.md)
- [ProQR Director Makes Bold Insider Move With New Share Purchase](https://longbridge.com/en/news/293410169.md)
- [Intel (INTC) Stock Looks Above Fair Value After Its 256% Run](https://longbridge.com/en/news/299431661.md)
- [Anthropic Says Claude Now Leads 26% of Its AI R&D, Up From Just 1% in March](https://longbridge.com/en/news/299423692.md)
- [3 AI Semiconductor Stocks with More Than 40% Upside and Recent 'Buy' Ratings](https://longbridge.com/en/news/299464643.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**